Inomagen Therapeutics Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
Inomagen Therapeutics General Information
Description
Developer of a novel biological (gene) therapy designed to improve the treatment of atrial fibrillation. The company's therapy is focused on improved methods of analysis and treatment for various mechanisms of atrial fibrillation, enabling physicians and researchers to gain access to potential tools to surpass cardiac ablation.
Contact Information
Website
www.inomagen.com
Formerly Known As
Rhythm Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
- 1375 West Fulton Avenue
- Suite 650
- Chicago, IL 60607
- United States
+1 (312) 000-0000
Inomagen Therapeutics Timeline
Inomagen Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 00000 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 11-Mar-2022 | 00.000 | 00000 | Completed | Clinical Trials - Phase 2 | |
| 4. Grant | 01-May-2021 | 00.000 | 00000 | Completed | Clinical Trials - Phase 1 | |
| 3. Grant | 14-Apr-2021 | 00.000 | 00000 | Completed | Clinical Trials - Phase 1 | |
| 2. Accelerator/Incubator | 15-Dec-2015 | $200K | Completed | Startup | ||
| 1. Angel (individual) | 21-Nov-2014 | $200K | $200K | Completed | Startup |
Inomagen Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Rishi Arora MD | Founder, President, Chief Executive Officer & Board Member | ||
| Scott Jordan | Chief Business Officer |
Inomagen Therapeutics Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| James Vogler JD | Self | Board Member & Advisor | 000 0000 |
| Mark Penn MD | Inomagen Therapeutics | Board Member & Advisor | 000 0000 |
| Peter McNerney | Self | Board Member & Advisor | 000 0000 |
| Rishi Arora MD | Inomagen Therapeutics | Founder, President, Chief Executive Officer & Board Member | 000 0000 |
Inomagen Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Inomagen Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| NIH Small Business Innovation Research | Government | Minority | 000 0000 | 000000 0 | |
| National Heart Blood and Lung Institute | Government | Minority | 000 0000 | 000000 0 | |
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| Matter (Specialized Finance) | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Portal Innovations | Venture Capital | Minority | 000 0000 | 000000 0 |